Arvee Laboratories Approves Quarter Ended June Financial Results and Finalizes AGM Details
Arvee Laboratories, a player in the chemical industry, has approved the unaudited standalone financial results for the quarter ending June 30, 2026. The company also finalized several operational matters ahead of its upcoming Annual General Meeting (AGM).During the Board meeting held on August 7, 2026, the company took various governance steps. Key decisions included approving the unaudited standalone financial results for the period ending June 30, 2026, which were supported by a limited review report from Statutory Auditors. The Board also approved the Directors Report for the year ended March 31, 2026.
Further outcomes of the board meeting included appointing Mr. Alkesh Jalan, Company Secretary in practice, as the Scrutiniser for the AGM. Additionally, the company fixed the date, time, and venue of the Annual General Meeting and approved the notice calling the AGM. The Board also decided to postpone a scheduled Scheme of Arrangement for further review of the matter.
Financial Performance Highlights (Quarter Ended June 30, 2026)
The un-audited financial results provide insights into revenue generation and profitability across various metrics. Revenue from Operations for the quarter ending June 30, 2026, stood at 1,722.53 T in Lakhs, with Other Income recorded at 18.09 T in Lakhs. Total Revenue for the period reached 1,740.61 T in Lakhs.Profit / (Loss) before tax was reported at 228.88 T in Lakhs, while Tax expense included Current Tax of 51.82 T in Lakhs and Deferred Tax of 7.65 T in Lakhs. The net Profit / (Loss) for the period from continuing operations was 169.41 T in Lakhs.
Key financial data points for the quarter ended June 30, 2026, compared to previous periods are summarized below:
| Financial Metric | Q ended June 30, 2026 (Un-Audited) | Q ended March 31, 2026 (Audited) | Q ended June 30, 2025 (Un-Audited) | Year ended March 31, 2026 (Audited) |
|---|---|---|---|---|
| Revenue from Operations (T in Lakhs) | 1,722.53 | 1,080.41 | 748.00 | 3,151.41 |
| Total Revenue (T in Lakhs) | 1,740.61 | 1,095.04 | 764.87 | 3,219.52 |
| Profit / (Loss) before Tax (T in Lakhs) | 228.88 | 85.37 | 17.42 | 243.04 |
Segmental Results and Capital Employed
The company provided a detailed overview of its segment performance, which is categorized into the Textile Chemical Segment (Films & Fibre) and the Non-textile Segment. The total revenue from operations stood at 1,740.61 T in Lakhs.Segment results showed that Profit / (Loss) before Tax and Interest for the non-textile segment was 204.96 T in Lakhs, compared to 29.99 T in Lakhs for the textile chemical segment. The total profit before tax across both segments was reported at 228.88 T in Lakhs.
Capital employed within the segments totaled 3,577.60 T in Lakhs, comprising 422.80 T in Lakhs from the Textile Chemical Segment and 3,154.80 T in Lakhs from the Non-textile Segment.
Audit Review Status
The Independent Auditor's Review Report confirmed that the Statement of Standalone Unaudited Financial Results for the quarter ended June 30, 2026, was prepared in accordance with Ind AS 34 'Interim Financial Reporting'. The review concluded that nothing came to their attention that suggested the accompanying statement contained any material misstatement or failed to disclose required information.ARVEE Stock Price Movement
On Friday, shares of Arvee Laboratories (India) Limited edged higher, settling at ₹156.52 after gaining 0.64% on the day. The stock traded within a range spanning from ₹155.70 to ₹158.79 and saw a total traded volume of 872 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: